Cite
HARVARD Citation
Yuen Chan, H. et al. (n.d.). IDDF2020-ABS-0061 Impact of treatment with tenofovir alafenamide (TAF) or tenofovir disoproxil fumarate (TDF) on hepatocellular carcinoma (HCC) incidence in patients with chronic hepatitis B (CHB). Gut. pp. A75-A76. [Online].